Kepu Biotech Co., Ltd.
凯普生物
300639
Shenzhen Stock Exchange
Key Financials
Announcements
Announcement on Wholly-Owned Subsidiary Obtaining Medical Device Registration Certificate
Legal Opinion from Guangdong Xinda Law Firm on the 2025 Annual Shareholders' Meeting of the Company
Announcement of Resolutions from the 2025 Annual Shareholders' Meeting
Reminder Announcement on Shareholding Reduction by Shareholders Holding More Than 5% of Shares Touching 1% and 5% Integer Multiples and Disclosure of Simplified Equity Change Report
Simplified Equity Change Report
Announcement on Changes in Shareholder Rights of Shareholders Holding More Than 5% of Shares Touching 1% Integer Multiple
Announcement of the 2025 Online Performance Briefing
Announcement on the Compensation Plan for Directors and Senior Management for 2026
Disclosure Notice for the Annual Report of 2025 and the First Quarter Report of 2026
Announcement on the Reappointment of Audit Institutions for the Year 2026
Independent Director Work Report for the Year 2025 (Chen Yingshi)
Independent Director Work Report for the Year 2025 (Qiao Youlin)
Independent Director Work Report for the Year 2025 (Yang Chunxue)
Internal Control Audit Report for the Year 2025
Internal Control Evaluation Report for the Year 2025
Work Regulations of the Compensation and Assessment Committee of the Board of Directors (April 2026)
Draft of the Compensation Management System for Directors and Senior Management
Management System for the Departure of Directors and Senior Management (April 2026)
Announcement on Changes to Certain Accounting Policies
Announcement on the Provision and Reversal of Asset Impairment for the First Quarter of 2026
Announcement on the Provision for Asset Impairment for the Year 2025
Notice of the 2025 Annual Shareholders' Meeting
Resolution Announcement of the Sixth Board of Directors' Fifth Meeting
Announcement on the Proposed Non-Distribution of Profits for 2025
2026 First Quarter Report
Special Report on the Company's 2025 Fundraising Fund Storage, Management, and Usage
CITIC Securities Co., Ltd. Special Verification Opinion on the Company's 2025 Fundraising Fund Storage and Usage
Verification Report on the Company's 2025 Fundraising Fund Storage, Management, and Usage Special Report
Verification Report on the Company's 2025 Operating Revenue Deduction Situation
2025 Evaluation Report on the Accounting Firm's Performance and Audit Committee's Report on the Accounting Firm's Supervisory Responsibilities
Special Report on the Company's 2025 Non-Operating Fund Occupation and Other Related Fund Transactions
Notes & Comments
Sign in to leave a comment or private note.
Loading…